Skip to content
ChickenStockChickenStock
ResearchALMR
Alamar Biosciences logo

Alamar Biosciences (ALMR) stock

NASDAQ

$30.81-2.99%(-0.95)

As of the Nov 13, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue in the latest quarter: $34M.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 4, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

40 SEC filings
  • Qiming Corporate GP VI, Ltd.10% owner · Nov 11, 2026Open-market sale100,117 shares · $2.9M
    Avg. price $29.3813
    Show 8 price lots
    • 62,944 shares × $29.34$1.8M
    • 17,584 shares × $29.34$516K
    • 14,687 shares × $29.34$431K
    • 2,084 shares × $30.63$64K
    • 1,694 shares × $29.34$50K
    • 582 shares × $30.63$18K
    • 486 shares × $30.63$15K
    • 56 shares × $30.63$2K
  • Qiming Corporate GP VI, Ltd.10% owner · Nov 3, 2026Open-market sale111,313 shares · $3.3M
    Avg. price $29.89
    Show 4 price lots
    • 72,301 shares × $29.89$2.2M
    • 20,196 shares × $29.89$604K
    • 16,870 shares × $29.89$504K
    • 1,946 shares × $29.89$58K
  • Qiming Corporate GP VI, Ltd.10% owner · Nov 2, 2026Open-market sale43,930 shares · $1.3M
    Avg. price $29.8436
    Show 8 price lots
    • 28,404 shares × $29.84$848K
    • 7,935 shares × $29.84$237K
    • 6,628 shares × $29.84$198K
    • 763 shares × $29.84$23K
    • 131 shares × $30.63$4K
    • 36 shares × $30.63$1K
    • 30 shares × $30.63$919
    • 3 shares × $30.63$92
  • Qiming Corporate GP VI, Ltd.10% owner · Oct 30, 2026Open-market sale143,706 shares · $4.4M
    Avg. price $30.3772
    Show 16 price lots
    • 48,659 shares × $29.93$1.5M
    • 40,112 shares × $30.7$1.2M
    • 13,593 shares × $29.93$407K
    • 11,205 shares × $30.7$344K
    • 11,354 shares × $29.93$340K
    • 9,359 shares × $30.7$287K
    • 3,400 shares × $31.96$109K
    • 1,309 shares × $29.93$39K
    • 1,169 shares × $33.31$39K
    • 1,080 shares × $30.7$33K
    • 950 shares × $31.96$30K
    • 793 shares × $31.96$25K
    • 327 shares × $33.31$11K
    • 273 shares × $33.31$9K
    • 92 shares × $31.96$3K
    • 31 shares × $33.31$1K
  • Qiming Corporate GP VI, Ltd.10% owner · Oct 28, 2026Open-market sale83,793 shares · $2.7M
    Avg. price $32.7656
    Show 4 price lots
    • 35,248 shares × $32.47$1.1M
    • 30,249 shares × $33.11$1.0M
    • 9,846 shares × $32.47$320K
    • 8,450 shares × $33.11$280K

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

27 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Alamar Biosciences (ALMR) stock information

NASDAQ

Alamar Biosciences (ALMR) is listed on NASDAQ. These figures are computed in-house from official filings and are reference information only.

Alamar Biosciences — frequently asked questions

Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.